{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T16:39:29Z","timestamp":1794069569739,"version":"4.8.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"C","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":154,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Perioperative chemotherapy could improve oncological outcomes for patients with advanced colon cancer. However, the effectiveness of triplet chemotherapy in the neoadjuvant setting is still unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Presentation of case<\/jats:title>\n                    <jats:p>A 61-year-old man was referred to our hospital due to abdominal distention. Abdominal computed tomography showed a huge, 18-cm mass in the right upper abdomen. Biopsy showed well-differentiated adenocarcinoma. Locally advanced transverse colon cancer T4b N2a M0 Stage IIIC was diagnosed. Considering the extensive invasion to surrounding organs and difficulties in achieving margin-negative surgery, an emergency ileostomy was performed first. Then, neoadjuvant chemotherapy (NAC) consisting of a combination of 5-fluorouracil (5-FU), oxaliplatin, irinotecan, and leucovorin (FOLFOXIRI) was planned, followed by primary tumor resection. After 6 courses of treatment, the primary tumor shrank remarkably. Finally, laparoscopic radical extended right hemi-colectomy was performed. There were no residual tumor cells in resected specimens, including the primary tumor and surrounding lymph nodes. The pathological diagnosis was complete response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A case of pathological complete response after neoadjuvant treatment followed by radical resection was reported. Further research is needed to confirm the appropriate indications for neoadjuvant FOLFOXIRI therapy for patients with LACC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1016\/j.ijscr.2020.05.077","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T02:21:43Z","timestamp":1591410103000},"page":"127-132","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["A pathological complete response after neoadjuvant triplet chemotherapy for locally advanced transverse colon cancer"],"prefix":"10.1097","volume":"72","author":[{"given":"Tetsuro","family":"Tominaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terumitsu","family":"Sawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nagayasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-29-20260114","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"R2-29-20260114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10147-019-01485-z","article-title":"Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer","volume":"25","author":"Hashiguchi","year":"2020","journal-title":"Int. J. Clin. Oncol"},{"key":"R3-29-20260114","first-page":"181","article-title":"Locally advanced colon cancer: evaluation of current clinical practice and treatment outcomes at the population level","volume":"15","author":"Klaver","year":"2017","journal-title":"J. Compr. Canc. Netw"},{"key":"R4-29-20260114","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/ans.14494","article-title":"Anastomotic leaks in stage IV colorectal cancer","volume":"88","author":"Ng","year":"2018","journal-title":"ANZ J. Surg"},{"key":"R5-29-20260114","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2407-7-86","article-title":"Factors influencing delay in the diagnosis of colorectal cancer: a study protocol","volume":"7","author":"Esteva","year":"2007","journal-title":"BMC Cancer"},{"key":"R6-29-20260114","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/SLA.0000000000000499","article-title":"JCOG0404 Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II\/III colon cancer: japan Clinical Oncology Group Study JCOG 0404","volume":"260","author":"Yamamoto","year":"2014","journal-title":"Ann. Surg"},{"key":"R7-29-20260114","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12094-016-1539-4","article-title":"Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery","volume":"19","author":"Arredondo","year":"2017","journal-title":"Clin. Transl. Oncol"},{"key":"R8-29-20260114","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/DCR.0b013e3181f2f202","article-title":"Surgical complications are associated with omission of chemotherapy for stage III colorectal cancer","volume":"53","author":"Hendren","year":"2010","journal-title":"Dis. Colon Rectum"},{"key":"R9-29-20260114","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S1470-2045(12)70348-0","article-title":"Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial","volume":"13","author":"Foxtrot Collaborative G","year":"2012","journal-title":"Lancet Oncol"},{"key":"R10-29-20260114","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/000313481908500418","article-title":"Clinical evaluation of preoperative radiotherapy combined with FOLFOX chemotherapy on patients with locally advanced colon cancer","volume":"85","author":"Zhou","year":"2019","journal-title":"Am. Surg"},{"key":"R11-29-20260114","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijsu.2018.10.028","article-title":"The SCARE 2018 statement: updating consensus surgical CAse REport (SCARE) guidelines","volume":"60","author":"Agha","year":"2018","journal-title":"Int. J. Surg"},{"key":"R12-29-20260114","doi-asserted-by":"crossref","first-page":"vi64","DOI":"10.1093\/annonc\/mdt354","article-title":"Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Labianca","year":"2013","journal-title":"Ann. Oncol"},{"key":"R13-29-20260114","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.ejca.2010.01.020","article-title":"Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis","volume":"46","author":"Des Guetz","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"R14-29-20260114","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1001\/jama.2011.749","article-title":"Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis","volume":"305","author":"Biagi","year":"2011","journal-title":"Jama"},{"key":"R16-29-20260114","first-page":"370","article-title":"Colon Cancer, version 1.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"Benson","year":"2017","journal-title":"J. Compr. Canc. Netw"},{"key":"R17-29-20260114","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2006.09.7758","article-title":"CLASICC2 randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group","volume":"25","author":"Jayne","year":"2007","journal-title":"J. Clin. Oncol"},{"key":"R18-29-20260114","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/codi.12119","article-title":"Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer","volume":"15","author":"Arredondo","year":"2013","journal-title":"Colorectal Dis"},{"key":"R19-29-20260114","first-page":"104","article-title":"Tumor response assessment in locally advanced colon cancer after neoadjuvant chemotherapy","volume":"5","author":"Arredondo","year":"2014","journal-title":"J. Gastrointest. Oncol"},{"key":"R20-29-20260114","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1245\/s10434-010-1506-1","article-title":"Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence","volume":"18","author":"de Campos-Lobato","year":"2011","journal-title":"Ann. Surg. Oncol"},{"key":"R21-29-20260114","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/bjs.8702","article-title":"Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer","volume":"99","author":"Martin","year":"2012","journal-title":"Br. J. Surg"},{"key":"R22-29-20260114","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1200\/JCO.2006.09.0928","article-title":"Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest","volume":"25","author":"Falcone","year":"2007","journal-title":"J. Clin. Oncol"},{"key":"R23-29-20260114","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/cam4.497","article-title":"Phase I\/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer","volume":"4","author":"Bazarbashi","year":"2015","journal-title":"Cancer Med"},{"key":"R24-29-20260114","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00384-018-3181-9","article-title":"Is adjuvant chemotherapy necessary for locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery? A systematic review and meta-analysis","volume":"34","author":"Ma","year":"2019","journal-title":"Int. J. Colorectal Dis"},{"key":"R25-29-20260114","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.ejso.2019.03.005","article-title":"Pathological complete response may underestimate distant metastasis in locally advanced rectal cancer following neoadjuvant chemoradiotherapy and radical surgery: Incidence, metastatic pattern, and risk factors","volume":"4","author":"Sun","year":"2019","journal-title":"Eur. J. Surg. Oncol"}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261220303783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261220303783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2020.05.077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:08:12Z","timestamp":1768396092000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1016\/j.ijscr.2020.05.077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":24,"journal-issue":{"issue":"C","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2020.05.077","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}